These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24585563)

  • 1. Editorial commentary: monitoring early warning indicators for HIV drug resistance in South Africa: challenges and opportunities.
    Rossouw TM
    Clin Infect Dis; 2014 Jun; 58(11):1615-7. PubMed ID: 24585563
    [No Abstract]   [Full Text] [Related]  

  • 2. Early warning indicators for HIV drug resistance in adults in South Africa at 2 pilot sites, 2008-2010.
    Dube NM; Tint KS; Summers RS
    Clin Infect Dis; 2014 Jun; 58(11):1607-14. PubMed ID: 24585566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.
    van Zyl GU; Frenkel LM; Chung MH; Preiser W; Mellors JW; Nachega JB
    AIDS; 2014 Nov; 28(18):2643-8. PubMed ID: 25493592
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the early warning indicators of HIV drug resistance surveillance system in Manicaland province, Zimbabwe.
    Marume A; Zikiti A; Chapoterera B; Maradzika J
    Afr J AIDS Res; 2019 Jul; 18(2):123-129. PubMed ID: 31282304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV in 2010: potent antiretroviral drugs treat and sensitive assays monitor the infection; but there remain outstanding issues.
    Antonelli G
    Clin Microbiol Infect; 2010 Oct; 16(10):1509-10. PubMed ID: 20854461
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mutations resulting in resistence of antiretroviral drugs in HIV-infected patients].
    Cabrera C; Clotet B
    Med Clin (Barc); 2005 Apr; 124(16):618-9. PubMed ID: 15871779
    [No Abstract]   [Full Text] [Related]  

  • 7. Is Genotype Testing Really Cost-Effective for Primary Resistance in Brazil?
    Ramos CG; Fisch P; Ferreira de Azeredo-Da-Silva AL
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):e54-6. PubMed ID: 26505332
    [No Abstract]   [Full Text] [Related]  

  • 8. Authors' Reply: Is Genotype Testing Really Cost-Effective for Primary Resistance in Brazil?
    Luz PM; Grinsztejn B; Veloso VG; Paltiel AD
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):e56. PubMed ID: 26579987
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.
    Mutenda N; Bukowski A; Nitschke AM; Nakanyala T; Hamunime N; Mekonen T; Tjituka F; Mazibuko G; Mwinga S; Mabirizi D; Sagwa E; Indongo R; Dean N; Jordan MR; Hong SY
    PLoS One; 2016; 11(12):e0166649. PubMed ID: 27906995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.
    Sigaloff KC; Hamers RL; Menke J; Labib M; Siwale M; Ive P; Botes ME; Kityo C; Mandaliya K; Wellington M; Osibogun A; Geskus RB; Stevens WS; van Vugt M; Rinke de Wit TF;
    Clin Infect Dis; 2012 May; 54 Suppl 4():S294-9. PubMed ID: 22544190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INFECTIOUS DISEASE. Researchers claim to find HIV sanctuaries.
    Cohen J
    Science; 2016 Jan; 351(6272):434. PubMed ID: 26823407
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transmission of antiretroviral drug resistant strains in patients diagnosed with human immunodeficiency virus infection in Gran Canaria in the period 2009-2012].
    Chamizo-López FJ; Gilarranz-Luengo R; Hernández-Febles M; Pena-López MJ
    Enferm Infecc Microbiol Clin; 2014 Dec; 32(10):695-6. PubMed ID: 24666476
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful use of a tipranavir/ritonavir-based antiretroviral regimen following development of viral resistance to darunavir.
    Pierone G; Urban T; Martin A; Mieras J; Kantor C
    HIV Clin Trials; 2008; 9(2):140-1. PubMed ID: 18474499
    [No Abstract]   [Full Text] [Related]  

  • 14. The Impact of HIV Drug Resistance on the Selection of First- and Second-Line ART in Resource-Limited Settings.
    Bertagnolio S; Perno CF; Vella S; Pillay D
    J Infect Dis; 2013 Jun; 207 Suppl 2():S45-8. PubMed ID: 23687288
    [No Abstract]   [Full Text] [Related]  

  • 15. (ARV-) Free State? The moratorium's threat to patients' adherence and the development of drug-resistant HIV.
    El-Khatib Z; Richter M
    S Afr Med J; 2009 Jun; 99(6):412, 414. PubMed ID: 19739316
    [No Abstract]   [Full Text] [Related]  

  • 16. Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008.
    Ma Y; Zhang F; Li H; Wu H; Zhang J; Ding Y; Zhao D; Fang H; Zhou S; Liu Z; Zhang L; Osborne C; Seguy N; Zhao Y
    Clin Infect Dis; 2012 May; 54 Suppl 4():S300-2. PubMed ID: 22544191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virological failure and drug resistance during first line anti-retroviral treatment in Indonesia.
    Fibriani A; Wisaksana R; Indrati A; Hartantri Y; van de Vijver D; Schutten M; Alisjahbana B; Sudjana P; Boucher CA; van Crevel R; van der Ven A
    J Med Virol; 2013 Aug; 85(8):1394-401. PubMed ID: 23722251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV Drug Resistance - An Emerging Threat to Epidemic Control.
    Beyrer C; Pozniak A
    N Engl J Med; 2017 Oct; 377(17):1605-1607. PubMed ID: 29069566
    [No Abstract]   [Full Text] [Related]  

  • 19. Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon.
    Meresse M; March L; Kouanfack C; Bonono RC; Boyer S; Laborde-Balen G; Aghokeng A; Suzan-Monti M; Delaporte E; Spire B; Carrieri MP; Laurent C;
    HIV Med; 2014 Sep; 15(8):478-87. PubMed ID: 24589279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.
    Pillay V; Ledwaba J; Hunt G; Rakgotho M; Singh B; Makubalo L; Bennett DE; Puren A; Morris L
    Antivir Ther; 2008; 13 Suppl 2():101-7. PubMed ID: 18575198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.